Every time a government launches a new disability support program, designs a rehabilitation initiative, or allocates healthcare resources, there’s a body of scientific evidence guiding those decisions. That evidence comes from epidemiology – a field that many people have heard of but fewer truly understand. At its core, epidemiology is the science of studying health patterns across populations, and it plays a foundational role in how we understand, measure, and respond to disability on a global scale.
Table of Contents
- What is epidemiology?
- Key terms you need to know
- Incidence
- Prevalence
- Burden of disease
- DALY: Disability-Adjusted Life Year
- Descriptive vs. analytic epidemiology
- Why epidemiology matters in disability studies
- Tracking disability trends
- Guiding resource allocation
- Designing targeted interventions
- Limitations and ethical considerations
What is epidemiology?
According to the National Institute on Deafness and Other Communication Disorders (NIDCD), epidemiology is the branch of medical science that investigates all the factors that determine the presence or absence of diseases and disorders. A more complete working definition, widely used in public health practice, is that epidemiology is the scientific, systematic, data-driven study of the distribution and determinants of health-related states or events in specified populations, and the application of this study to the control of health problems.
There are three key ideas packed into that definition. First, epidemiology is about populations, not just individuals. Where a clinician focuses on diagnosing and treating a single patient, an epidemiologist asks: how many people are affected, where are they, and why? Second, it studies distribution – the patterns of who gets sick, when, and where. Third, it looks at determinants – the causes and risk factors that drive those patterns. The ultimate aim is not just to describe but to act: to use findings to prevent and control health problems.
Britannica traces the roots of the word to the Greek epi (upon), demos (people), and logos (study) – essentially, the study of what falls upon a population. One of epidemiology’s most celebrated early examples comes from 1854, when physician John Snow traced a cholera outbreak in London to a contaminated water pump on Broad Street. By mapping deaths and identifying the common source, he helped lay the groundwork for modern epidemiological method – long before germ theory was even established.
Key terms you need to know
Epidemiology has its own precise vocabulary. Understanding these terms is essential for reading health data and disability statistics accurately.
Incidence
Incidence refers to the number of new cases of a disease or disorder appearing in a population over a specific period of time. It is essentially a measure of risk – it tells you how fast a condition is spreading or emerging. For example, if 500 people in a city of one million develop a hearing impairment in a given year, that figure represents the annual incidence of hearing impairment in that population. As the NIDCD explains, incidence captures new cases entering a population during a defined timeframe.
Prevalence
Prevalence counts all existing cases – both new and old – of a condition in a population at a given point in time or over a period. It reflects the total burden a condition places on a community right now. In epidemiological terms, prevalence is a measure of disease burden, while incidence is a measure of disease risk. The distinction matters practically: a condition like spinal cord injury may have low annual incidence (few new cases each year) but high prevalence (because those who acquire it live with it for decades).
Burden of disease
Burden of disease is a broader concept that captures the total significance of a health condition for society – going beyond just the number of cases or deaths. As defined by NIDCD, adapting the WHO framework, burden of disease accounts for the total impact of illness measured in years of life lost to ill health – essentially the gap between a population’s current health and an ideal situation where everyone lives to old age in full health.
DALY: Disability-Adjusted Life Year
The most widely used metric for measuring disease burden is the DALY (Disability-Adjusted Life Year). As Our World in Data explains, one DALY represents one lost year of healthy life – lost either to premature death or to living with illness or disability. The formula is straightforward: DALY = YLL + YLD, where YLL stands for Years of Life Lost due to premature death, and YLD stands for Years Lived with Disability.
According to WHO’s Global Health Estimates, DALYs from communicable diseases like HIV/AIDS and diarrhoeal diseases dropped by over 50% since 2000, while DALYs from conditions like diabetes and Alzheimer’s disease more than doubled between 2000 and 2021. This shift signals a global epidemiological transition – from infectious diseases to chronic, non-communicable conditions that often result in long-term disability.
DALYs were first developed by Christopher Murray and Alan Lopez through the WHO’s Global Burden of Disease Study in 1990, and as researchers at the Rhode Island Department of Health have demonstrated, using DALYs to assess health burden produces a very different picture than mortality statistics alone – particularly because many disabling conditions don’t kill people but significantly reduce quality of life for decades.
Descriptive vs. analytic epidemiology
Epidemiology operates through two main approaches. Descriptive epidemiology identifies patterns among cases and populations by examining three dimensions: person (who is affected), place (where they are), and time (when cases occur). This approach answers the “what” and “who” questions – mapping the landscape of a health condition. Analytic epidemiology, by contrast, digs into the “why” and “how.” It uses comparison groups and study designs to identify causes, test hypotheses, and assess the relationship between risk factors and health outcomes. As the University of North Dakota notes, epidemiologists collect and analyze data specifically to identify patterns, causes, and to recommend disease prevention and control strategies.
Why epidemiology matters in disability studies
Disability does not affect all populations equally, and understanding those disparities requires precisely the kind of systematic, population-level analysis that epidemiology provides. Disability epidemiology – a subdiscipline that applies epidemiological methods specifically to disability – focuses on the distribution, determinants, correlates, and outcomes of disability with the goal of maximizing health and quality of life for people with disabilities. It draws on the WHO’s International Classification of Functioning, Disability and Health (ICF), which frames disability not merely as a medical diagnosis but as the result of interactions between a person’s health condition and their environment.
Tracking disability trends
Epidemiological data makes it possible to monitor whether disability rates are rising or falling, which populations are most affected, and whether interventions are working. The Global Burden of Disease Study 2016 demonstrated that measuring changes in DALYs and healthy life expectancy across countries is critical for identifying specific needs for resource allocation in research, policy development, and programme decision-making. Without this data, health systems are essentially planning in the dark.
Guiding resource allocation
When policymakers decide which conditions to prioritize for funding, rehabilitation services, or public health campaigns, epidemiological data is the primary evidence base. Incidence and prevalence data reveal where the greatest need exists, while DALYs show which conditions impose the largest burden on population health. As ScienceDirect summarizes, effective population-based public health measures – including the distribution of resources for healthcare and prevention – are planned using the results of epidemiological studies.
Designing targeted interventions
Epidemiology also identifies which sub-groups are at highest risk, enabling health programs to be targeted where they’re most needed rather than applied uniformly. The Lancet’s Global Burden of Disease Study 2021 underscored the ongoing importance of prioritising non-communicable disease prevention policies and strengthening health systems – findings that are directly relevant for planning disability-inclusive rehabilitation services. Epidemiological evidence can reveal, for instance, that disability from musculoskeletal conditions disproportionately affects working-age adults in low-income settings, prompting targeted community-based rehabilitation programs rather than only hospital-based care.
Limitations and ethical considerations
Epidemiology is a powerful tool, but it has limitations. Data quality varies significantly between countries, and populations in low- and middle-income settings are often underrepresented in global studies. There are also ongoing ethical debates about the DALY metric itself. Critics published in PMC have argued that the disability weighting system embedded in DALYs implicitly assigns lower value to the lives of people with disabilities – a concern that sits in direct tension with the rights-based principles of inclusive healthcare. Epidemiologists and disability scholars continue to refine these tools, pushing for disability weights that better reflect the lived experience and social participation of people with disabilities, rather than expert panels’ perceptions of what it means to live with a condition.
These critiques don’t diminish the importance of epidemiology – they strengthen it. A field that is open to scrutiny and continuous refinement is one that produces more reliable, equitable, and actionable evidence.
What do you think? Given that DALYs are still the dominant tool for measuring disease burden globally, should health systems invest more in developing disability-specific metrics grounded in the lived experience of people with disabilities? And how might the patterns revealed by epidemiological data change the way communities design rehabilitation and support services for people with disabilities?
References
- https://www.nidcd.nih.gov/health/statistics/what-epidemiology
- https://archive.cdc.gov/www_cdc_gov/csels/dsepd/ss1978/lesson1/section1.html
- https://www.britannica.com/science/epidemiology
- https://libguides.acom.edu/ph/epi
- https://ourworldindata.org/burden-of-disease
- https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/global-health-estimates-leading-causes-of-dalys
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3314073/
- https://und.edu/blog/epidemiology-vs-public-health.html
- https://methods.sagepub.com/reference/encyc-of-epidemiology/n112.xml
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5605707/
- https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/epidemiology
- https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00757-8/fulltext
- https://pmc.ncbi.nlm.nih.gov/articles/PMC1117148/
Leave a Reply